Paraneoplastic neurological syndromes and the role of PET imaging

Oncology. 2010;78(2):150-6. doi: 10.1159/000312657. Epub 2010 Apr 13.

Abstract

Paraneoplastic neurological syndromes are immune-mediated effects of cancer that involve the nervous system and are associated with various anti-neuronal antibodies. They can be associated with several cancers such as lung, gynecologic, thymic, testicular and others, but the diagnosis of cancer often becomes a challenge, since paraneoplastic neurological syndromes usually precede the cancer presentation by months or even years. Furthermore, even when the cancer develops, the tumor size remains small and usually undetectable by conventional diagnostic tests and imaging. Positron emission tomography imaging may be an adjunct to timely diagnosis of the occult malignancy in order to employ the specific cancer treatment. Furthermore, positron emission tomography can assess the extent of the functional abnormality in the brain and monitor its response to treatment.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / pathology
  • Dementia / etiology
  • Diagnosis, Differential
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Immunotherapy / methods
  • Lambert-Eaton Myasthenic Syndrome / diagnostic imaging
  • Magnetic Resonance Imaging
  • Ovarian Neoplasms / diagnostic imaging
  • Ovarian Neoplasms / pathology
  • Paraneoplastic Syndromes / diagnosis
  • Paraneoplastic Syndromes / diagnostic imaging*
  • Paraneoplastic Syndromes / pathology
  • Paraneoplastic Syndromes, Nervous System / diagnosis
  • Paraneoplastic Syndromes, Nervous System / diagnostic imaging*
  • Paraneoplastic Syndromes, Nervous System / immunology
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Seizures / etiology
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18